{"protocolSection":{"identificationModule":{"nctId":"NCT06482281","orgStudyIdInfo":{"id":"2022-06312"},"organization":{"fullName":"Karolinska Institutet","class":"OTHER"},"briefTitle":"COVID-19 and Childhood Cancer","officialTitle":"COVID-19 and Childhood Cancer - Diagnostic Delay, Survival, and COVID-19 Susceptibility"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-01-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-28","studyFirstSubmitQcDate":"2024-06-28","studyFirstPostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"},"lastUpdateSubmitDate":"2024-06-28","lastUpdatePostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Giorgio Tettamanti","investigatorTitle":"Senior research specialist, Docent","investigatorAffiliation":"Karolinska Institutet"},"leadSponsor":{"name":"Karolinska Institutet","class":"OTHER"},"collaborators":[{"name":"The Swedish Research Council","class":"OTHER_GOV"},{"name":"The Swedish Childhood Cancer Fund","class":"UNKNOWN"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The investigators will first examine the impact of the COVID-19 pandemic on childhood cancer patients in Sweden and Denmark, both regarding susceptibility to severe COVID-19 among long-term childhood cancer survivors, and, for those diagnosed with childhood cancer during the pandemic, whether the path through primary care to cancer diagnosis as well as short-term survival has changed. Second, the investigators will study childhood cancer incidence before, during and after the pandemic with the particular aim to test the hypothesis regarding an infectious disease etiology for acute lymphoblastic leukemia."},"conditionsModule":{"conditions":["COVID-19","Childhood Cancer","Childhood Leukemia, Acute Lymphoblastic"],"keywords":["Childhood Cancer","Childhood Cancer Incidence","Childhood Cancer Survival","Childhood Leukemia, Acute Lymphoblastic","Cohort Study","Register Study"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"RETROSPECTIVE"},"enrollmentInfo":{"count":100000,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Childhood cancer survivors","description":"Childhood cancer cases (0-19 years old) reported to the national cancer registers from 1971 in Sweden and Denmark, who were alive five years after the cancer diagnosis"},{"label":"Matched comparisons","description":"Five general population comparisons were randomly selected and matched to the childhood cancer survivors by sex and year of birth"},{"label":"Siblings","description":"All siblings of the childhood cancer survivors"},{"label":"Childhood cancer cases","description":"Childhood cancer cases (0-19 years old) reported to the national cancer registers from 2015 in Sweden and Denmark. They will then further divided in three groups: before the pandemic (2015-2019), during the pandemic (2020-2022), and after the pandemic (2022-)"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Severe COVID-19","description":"Defined as:\n\n* death with COVID-19 listed as a cause of death\n* hospitalization, or admission to intensive care unit, because of COVID-19 (main diagnosis) or respiratory problems (main diagnosis) AND COVID-19 as secondary diagnosis","timeFrame":"Up to 3 years"},{"measure":"Childhood cancer survival","description":"Overall survival after a childhood cancer diagnosis","timeFrame":"After three and twelve months after the cancer diagnosis and three years after cancer diagnosis"},{"measure":"Number of contacts before childhood cancer diagnosis","description":"Number of healthcare contacts (including primary care) the year before the cancer diagnosis","timeFrame":"One year before cancer diagnosis"},{"measure":"Childhood cancer incidence","description":"Age standardized incidence rates for childhood cancer and cancer subtypes (particularly acute lymphoblastic leukemia) in Sweden and Denmark during and after the pandemic and compare it to the 5 years preceding the pandemic","timeFrame":"From 2015"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria for studying severe COVID-19 among childhood cancer survivors:\n\n* Childhood cancer cases (age 0-19) diagnosed from 1971 in Sweden and Denmark who were alive five years after diagnosis\n* Two different comparisons groups: five age- and sex-matched comparisons for each childhood cancer survivor as well as all siblings of the childhood cancer survivors.\n\nAll childhood cancer survivors, matched comparisons, and siblings of the survivors should be 20+ at the start of 2020.\n\nInclusion Criteria for studying childhood cancer incidence and survival and number of contacts with healthcare before the childhood cancer diagnosis:\n\n- All children (age 0-19) diagnosed with cancer from 2015 in Sweden and Denmark\n\nExclusion Criteria:\n\n* No exclusion criteria","healthyVolunteers":true,"sex":"ALL","minimumAge":"0 Years","maximumAge":"19 Years","stdAges":["CHILD","ADULT"],"studyPopulation":"* Childhood cancer cases (age 0-19) diagnosed from 1971 in Sweden and Denmark who were alive five years after diagnosis + their matched comparisons AND all siblings of the childhood cancer survivors\n* All children (age 0-19) diagnosed with cancer from 2015 in Sweden and Denmark","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Giorgio Tettamanti, PhD","affiliation":"Karolinska Institutet","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Karolinska Institutet","city":"Stockholm","zip":"17177","country":"Sweden","geoPoint":{"lat":59.33258,"lon":18.0649}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000086382","term":"COVID-19"},{"id":"D000054198","term":"Precursor Cell Lymphoblastic Leukemia-Lymphoma"}],"ancestors":[{"id":"D000007938","term":"Leukemia"},{"id":"D000009370","term":"Neoplasms by Histologic Type"},{"id":"D000009369","term":"Neoplasms"},{"id":"D000006402","term":"Hematologic Diseases"},{"id":"D000011024","term":"Pneumonia, Viral"},{"id":"D000011014","term":"Pneumonia"},{"id":"D000012141","term":"Respiratory Tract Infections"},{"id":"D000007239","term":"Infections"},{"id":"D000014777","term":"Virus Diseases"},{"id":"D000018352","term":"Coronavirus Infections"},{"id":"D000003333","term":"Coronaviridae Infections"},{"id":"D000030341","term":"Nidovirales Infections"},{"id":"D000012327","term":"RNA Virus Infections"},{"id":"D000008171","term":"Lung Diseases"},{"id":"D000012140","term":"Respiratory Tract Diseases"},{"id":"D000007945","term":"Leukemia, Lymphoid"},{"id":"D000008232","term":"Lymphoproliferative Disorders"},{"id":"D000008206","term":"Lymphatic Diseases"},{"id":"D000007160","term":"Immunoproliferative Disorders"},{"id":"D000007154","term":"Immune System Diseases"}],"browseLeaves":[{"id":"M2561","name":"COVID-19","asFound":"COVID-19","relevance":"HIGH"},{"id":"M10945","name":"Leukemia","relevance":"LOW"},{"id":"M7380","name":"Disease Susceptibility","relevance":"LOW"},{"id":"M11220","name":"Lymphoma","relevance":"LOW"},{"id":"M27585","name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","asFound":"Leukemia, Acute Lymphoblastic","relevance":"HIGH"},{"id":"M10951","name":"Leukemia, Lymphoid","relevance":"LOW"},{"id":"M12315","name":"Neoplasms by Histologic Type","relevance":"LOW"},{"id":"M9490","name":"Hematologic Diseases","relevance":"LOW"},{"id":"M13904","name":"Pneumonia","relevance":"LOW"},{"id":"M13914","name":"Pneumonia, Viral","relevance":"LOW"},{"id":"M10283","name":"Infections","relevance":"LOW"},{"id":"M6368","name":"Communicable Diseases","relevance":"LOW"},{"id":"M14978","name":"Respiratory Tract Infections","relevance":"LOW"},{"id":"M17522","name":"Virus Diseases","relevance":"LOW"},{"id":"M20490","name":"Coronavirus Infections","relevance":"LOW"},{"id":"M6555","name":"Coronaviridae Infections","relevance":"LOW"},{"id":"M23685","name":"Nidovirales Infections","relevance":"LOW"},{"id":"M15149","name":"RNA Virus Infections","relevance":"LOW"},{"id":"M11168","name":"Lung Diseases","relevance":"LOW"},{"id":"M14977","name":"Respiratory Tract Diseases","relevance":"LOW"},{"id":"M11225","name":"Lymphoproliferative Disorders","relevance":"LOW"},{"id":"M11203","name":"Lymphatic Diseases","relevance":"LOW"},{"id":"M10206","name":"Immunoproliferative Disorders","relevance":"LOW"},{"id":"M10200","name":"Immune System Diseases","relevance":"LOW"},{"id":"T1134","name":"Childhood Acute Lymphoblastic Leukemia","asFound":"Childhood Leukemia, Acute Lymphoblastic","relevance":"HIGH"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"},{"id":"T3543","name":"Lymphosarcoma","relevance":"LOW"},{"id":"T175","name":"Acute Lymphoblastic Leukemia","asFound":"Leukemia, Acute Lymphoblastic","relevance":"HIGH"},{"id":"T3533","name":"Lymphoblastic Lymphoma","asFound":"Leukemia, Acute Lymphoblastic","relevance":"HIGH"}],"browseBranches":[{"abbrev":"BC01","name":"Infections"},{"abbrev":"BC08","name":"Respiratory Tract (Lung and Bronchial) Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC04","name":"Neoplasms"},{"abbrev":"BC15","name":"Blood and Lymph Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC20","name":"Immune System Diseases"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}